| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |